In addition, overexpression of CXCR6 is associated with poor prognosis in prostate cancer [49], gastric cancer [50], and renal cancer [51], especially prostate cancer CXCR6 which is an independent predictor of poor prognosis, and its overexpression is a risk factor [49]. Here, CXCR6 is linked to prostate cancer.